Total raised
$3.2M
Last: Equity crowdfunding 2020-09
Stage
Series A
Founded
2014
Headcount
3
HQ
—
Sector
Health Tech & Life Sciences
About
Concenter BioPharma develops drugs for treating and preventing type 2 diabetes. The company has developed a family of nonsteroidal chemical complexes made from components approved for clinical use. These new chemical entities constitute a protected platform of drugs with proven efficacy and safety. The members of the platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents. These modes of action jointly assist in treating the causes and/or symptoms of multiple indications. Concenter BioPharma is a subsidiary of Silkim Pharma.
Funding history · 2 rounds · $3.2M total
2020-09
Equity crowdfunding
$1.2M
2016-05
Series A
$2.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
biopharmaceuticalbiotechnologyinflammatory-diseasespharma-companiesoral-drugsdrug-discoverydiabetespharmaceuticalsdrug-developmenttype-2-diabetes